At a glance
- Originator Shionogi
- Class Antiepileptic drugs; Antihypertensives; Neuroprotectants; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy; Hypertension; Ischaemic heart disorders; Neurological disorders
Most Recent Events
- 30 Jun 1998 Discontinued-I for Epilepsy in Japan (Unknown route)
- 30 Jun 1998 Discontinued-I for Ischaemic heart disorders in Japan (Unknown route)
- 30 Jun 1998 Discontinued-II for Hypertension in Japan (PO)